Amplification of oncogenes such as theepidermal growth factor receptor (EGFR), as well as loss oftumor suppressors like PTEN on chromosome 10, p53 on hromosome 17,or p16/INK4A are some of the most common genetic alterations in GBM[11, 12]. The gene discussed is PTEN; the disease is glioblastoma.